解剖病理学市場

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2021年11月

解剖病理学市場:製品とサービス機器（セルプロセッサ、ミクロトーム）、消耗品、組織病理学、細胞病理学、用途（疾患診断（がん（乳房、肺）、エンドユーザー（病院研究所）、地域別 – 2026年までの世界予測

Anatomic Pathology Market by Product & Service (Instruments (Cell Processor, Microtome), Consumable, Histopathology, Cytopathology, Application (Disease Diagnosis (Cancer (Breast, Lung), End User (Hospital Laboratories), Region – Global Forecasts to 2026

–

–

The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine. In addition, emerging economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the anatomic pathology market during the forecast period.
“The anatomic pathology services segment accounted for the highest growth rate in the anatomic pathology market, by product and service, during the forecast period”
Based on product & service, the anatomic pathology market is segmented into services, consumables, and instruments. The anatomic pathology services segment is projected to register the highest CAGR during the forecast period. The growth of this segment is primarily driven by rapid growing geriatric population and the increasing incidence of cancer and other chronic diseases.
“Disease Diagnostics accounted for the highest CAGR”
Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment is projected to register the highest CAGR during the forecast period. This can be attributed to rising geriatric population and the increasing incidence of cancer and other chronic diseases.
“Hospital laboratories accounted for the highest CAGR”
Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. Hospital laboratories is projected to register the highest CAGR during the forecast period. Increasing number of patient visits to hospitals, the growing number of in-house diagnostic procedures performed in hospitals, and growing awareness regarding early disease diagnosis are major factors contributing to growth of the segment.

“Asia Pacific: The fastest-growing region in the Anatomic pathology market”
The anatomic pathology market is segmented into North America, Europe, Asia Pacific, and Rest of the World. The Asia Pacific region offers high-growth opportunities for players in the anatomic pathology market. The presence of emerging economies like China and India, the large population in APAC countries, rising prevalence of chronic diseases, improving standard of living, growing demand for quality medical care, increasing healthcare spending and government initiatives, and rising awareness about the use of anatomic pathology tests among physicians are the major factors driving market growth in the Asia Pacific region.

The primary interviews conducted for this report can be categorized as follows:

•By Company Type: Tier 1 – 28%, Tier 2 – 42%, and Tier 3 – 30%
•By Designation: C-level – 30%, D-level – 34%, and Others – 36%
•By Region: North America- 46%, Europe- 25%, Asia Pacific – 18%, RoW – 11%
Lists of Companies Profiled in the Report:

•F. Hoffmann-La Roche Ltd. (Switzerland)
•Danaher Corporation (US)
•PHC Holdings Corporation (Japan)
•Becton, Dickinson and Company (US)
•Abcam plc (UK)
•Agilent Technologies, Inc. (US)
•Hologic, Inc. (US)
•Merck KGaA (Germany)
•Bio SB (US)
•Diapath S.p.A. (Italy)
•Histo-Line Laboratories (Italy)
•Milestone Medical (Italy)
•SLEE medical GmbH (Germany)
•BioGenex (US)
•Sakura Finetek (US)
•Amos Scientific Pty Ltd. (Australia)
•MEDITE Medical GmbH (Germany)
•Cell Signaling Technology, Inc. (US)
•CellPath Ltd. (UK)
•Jinhua Yidi Medical Equipment Co., Ltd. (China)
•MICROS AUSTRIA (Austria)
•R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED (India)
•Lupetec (Brazil)
•Medimeas (India)
•Bright Instruments (UK)
Research Coverage:
This report provides a detailed picture of the anatomic pathology market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall anatomic pathology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, opportunities, challenges, and trends.

目次

1INTRODUCTION51
1.1OBJECTIVES OF THE STUDY51
1.2MARKET DEFINITION51
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY51
1.3MARKET SCOPE52
1.3.1MARKETS COVERED52
FIGURE 1ANATOMIC PATHOLOGY MARKET SEGMENTATION52
1.3.2YEARS CONSIDERED FOR THE STUDY53
1.4CURRENCY53
1.5STAKEHOLDERS53
1.6SUMMARY OF CHANGES54
2RESEARCH METHODOLOGY55
2.1RESEARCH DATA55
FIGURE 2RESEARCH DESIGN55
2.1.1SECONDARY DATA56
2.1.1.1Secondary sources57
2.1.2PRIMARY DATA57
2.1.2.1Key data from primary sources58
2.1.2.2Key industry insights59
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (ANATOMIC PATHOLOGY MARKET)59
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION60
2.2MARKET SIZE ESTIMATION60
2.2.1APPROACH 1: REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)60
2.2.1.1Bottom-up approach for the instruments and consumables market61
FIGURE 5MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH61
2.2.2APPROACH 2: SECONDARY DATA & PRIMARY INTERVIEWS61
2.2.3APPROACH 3: TOP-DOWN APPROACH61
FIGURE 6MARKET SIZE ESTIMATION: TOP-DOWN APPROACH62
2.2.3.1Services market estimation based on the number of tests62
2.2.3.2Services market estimation based on procedures63
FIGURE 7CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS IN THE ANATOMIC PATHOLOGY MARKET
(2021–2026)64
FIGURE 8CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS64
2.3MARKET BREAKDOWN AND DATA TRIANGULATION65
FIGURE 9DATA TRIANGULATION METHODOLOGY65
2.4MARKET SHARE ANALYSIS66
2.5ASSUMPTIONS FOR THE STUDY66
2.6RISK ASSESSMENT67
TABLE 1RISK ASSESSMENT: ANATOMIC PATHOLOGY MARKET67
2.6.1COVID-19 SPECIFIC ASSUMPTIONS67
2.7LIMITATIONS68
2.7.1METHODOLOGY-RELATED LIMITATIONS68
2.7.2SCOPE-RELATED LIMITATIONS68
2.8GROWTH RATE ASSUMPTIONS68
2.9COVID-19 ECONOMIC ASSESSMENT68
2.10ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO69
FIGURE 11RECOVERY SCENARIO OF THE GLOBAL ECONOMY70
3EXECUTIVE SUMMARY71
FIGURE 12ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021 VS. 2026 (USD MILLION)71
FIGURE 13ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)72
FIGURE 14ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)72
FIGURE 15ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)73
FIGURE 16ANATOMIC PATHOLOGY MARKET, BY END USER,
2021 VS. 2026 (USD MILLION)73
FIGURE 17ANATOMIC PATHOLOGY MARKET: REGIONAL SNAPSHOT74
4PREMIUM INSIGHTS75
4.1ANATOMIC PATHOLOGY MARKET OVERVIEW75
FIGURE 18HIGH INCIDENCE OF CANCER TO DRIVE MARKET GROWTH75
4.2NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE76
FIGURE 19SERVICES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE
NORTH AMERICAN ANATOMIC PATHOLOGY MARKET76
4.3GEOGRAPHICAL SNAPSHOT OF THE ANATOMIC PATHOLOGY MARKET77
FIGURE 20COUNTRIES IN THE ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD77
5MARKET OVERVIEW78
5.1INTRODUCTION78
5.2MARKET DYNAMICS78
FIGURE 21ANATOMIC PATHOLOGY MARKET: DRIVERS, OPPORTUNITIES, CHALLENGES, AND TRENDS78
5.2.1DRIVERS79
5.2.1.1High incidence of cancer and other target diseases79
TABLE 2INCREASING INCIDENCE OF CANCER, BY REGION,
2020 VS. 2030 VS. 2040 (MILLION)79
TABLE 3PROJECTED INCREASE IN THE GLOBAL NUMBER OF CANCER PATIENTS,
2015 VS. 2018 VS. 203579
5.2.1.2Recommendations for cancer screening80
5.2.1.3Availability of reimbursement80
5.2.1.4Growing focus on personalized medicine81
TABLE 4% OF PERSONALIZED MEDICINES IN OVERALL DRUG APPROVAL BY FDA, 2014 TO 202081
5.2.2OPPORTUNITIES82
5.2.2.1Increasing number of clinical trials pertaining to cancer drugs82
5.2.2.2Emerging markets offer lucrative opportunities82
5.2.2.3Companion diagnostics83
5.2.3CHALLENGES83
5.2.3.1Availability of refurbished products83
5.2.3.2Lack of skilled professionals84
TABLE 5NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 201884
5.2.3.3Product failures and recalls84
5.2.3.4Inadequate infrastructure and low awareness in middle- and low-income countries84
5.2.4TRENDS85
5.2.4.1Reagent rental agreements85
5.2.5IMPACT OF COVID-19 ON THE ANATOMIC PATHOLOGY MARKET85
5.3TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES86
5.4RANGES/SCENARIOS87
5.4.1ANATOMIC PATHOLOGY MARKET87
FIGURE 22PESSIMISTIC SCENARIO87
FIGURE 23OPTIMISTIC SCENARIO87
FIGURE 24REALISTIC SCENARIO88
5.5PRICING ANALYSIS88
TABLE 6PRICES OF ANATOMIC PATHOLOGY PRODUCTS88
5.6VALUE CHAIN ANALYSIS89
FIGURE 25MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASES89
5.7SUPPLY CHAIN ANALYSIS90
FIGURE 26DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES90
5.8ECOSYSTEM ANALYSIS91
5.8.1ROLE IN THE ECOSYSTEM91
FIGURE 27KEY PLAYERS IN THE ANATOMIC PATHOLOGY ECOSYSTEM92
5.9TECHNOLOGY ANALYSIS92
TABLE 7TECHNOLOGICAL ADVANCEMENT IN THE ANATOMIC PATHOLOGY MARKET (2018–2021)92
5.10REGULATORY LANDSCAPE93
FIGURE 28510(K) APPROVAL PROCESS93
5.11PATENT ANALYSIS94
5.12TRADE ANALYSIS95
5.12.1TRADE ANALYSIS FOR TISSUE PROCESSING SYSTEMS95
TABLE 8IMPORT DATA FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION)95
TABLE 9EXPORT DATA FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY,
2016–2020 (USD MILLION)95
5.13PORTER’S FIVE FORCES ANALYSIS95
TABLE 10PORTER’S FIVE FORCES ANALYSIS (2020): ANATOMIC PATHOLOGY MARKET96
5.13.1THREAT OF NEW ENTRANTS96
5.13.2INTENSITY OF COMPETITIVE RIVALRY96
5.13.3BARGAINING POWER OF BUYERS96
5.13.4BARGAINING POWER OF SUPPLIERS96
5.13.5THREAT OF SUBSTITUTES96
6ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE97
6.1INTRODUCTION98
TABLE 11ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)98
TABLE 12ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)98
6.1.1PRIMARY NOTES98
6.1.1.1Key industry insights98
6.2SERVICES99
TABLE 13ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)99
TABLE 14ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)99
6.2.1HISTOPATHOLOGY SERVICES99
6.2.1.1Rising incidence of cancer is a key factor driving market growth99
FIGURE 29STEPS IN HISTOPATHOLOGY SLIDE PREPARATION99
TABLE 15HISTOPATHOLOGY SERVICES MARKET, BY REGION,
2016–2020 (USD MILLION)100
TABLE 16HISTOPATHOLOGY SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION)100
6.2.2CYTOPATHOLOGY SERVICES100
6.2.2.1Government focus on cervical cancer screening has boosted the growth of the cytopathology services market100
TABLE 17CYTOPATHOLOGY SERVICES MARKET, BY REGION,
2016–2020 (USD MILLION)101
TABLE 18CYTOPATHOLOGY SERVICES MARKET, BY REGION,
2021–2026 (USD MILLION)101
6.3CONSUMABLES102
TABLE 19ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)102
TABLE 20ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)102
6.3.1ANTIBODIES102
TABLE 21ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)103
TABLE 22ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)103
6.3.1.1Primary antibodies103
6.3.1.1.1High specificity and accuracy of primary antibodies to drive the market103
TABLE 23PRIMARY ANTIBODIES MARKET, BY REGION, 2016–2020 (USD MILLION)104
TABLE 24PRIMARY ANTIBODIES MARKET, BY REGION, 2021–2026 (USD MILLION)104
6.3.1.2Secondary antibodies104
6.3.1.2.1Versatility of secondary antibodies ensuring their stable demand among end users104
TABLE 25SECONDARY ANTIBODIES MARKET, BY REGION, 2016–2020 (USD MILLION)105
TABLE 26SECONDARY ANTIBODIES MARKET, BY REGION, 2021–2026 (USD MILLION)105
6.3.2KITS & REAGENTS105
TABLE 27KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)106
TABLE 28KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)106
6.3.2.1Stains & solvents106
6.3.2.1.1Introduction of automation can limit the market growth106
TABLE 29STAINS & SOLVENTS MARKET, BY REGION, 2016–2020 (USD MILLION)107
TABLE 30STAINS & SOLVENTS MARKET, BY REGION, 2021–2026 (USD MILLION)107
6.3.2.2Fixatives107
6.3.2.2.1Adoption of non-toxic fixatives to drive market growth107
TABLE 31FIXATIVES MARKET, BY REGION, 2016–2020 (USD MILLION)108
TABLE 32FIXATIVES MARKET, BY REGION, 2021–2026 (USD MILLION)108
6.3.2.3Other kits & reagents108
TABLE 33OTHER KITS & REAGENTS MARKET, BY REGION, 2016–2020 (USD MILLION)109
TABLE 34OTHER KITS & REAGENTS MARKET, BY REGION, 2021–2026 (USD MILLION)109
6.3.3PROBES109
6.3.3.1Increasing research to aid the market growth109
TABLE 35PROBES MARKET, BY REGION, 2016–2020 (USD MILLION)110
TABLE 36PROBES MARKET, BY REGION, 2021–2026 (USD MILLION)110
6.3.4OTHER CONSUMABLES110
TABLE 37OTHER CONSUMABLES MARKET, BY REGION, 2016–2020 (USD MILLION)111
TABLE 38OTHER CONSUMABLES MARKET, BY REGION, 2021–2026 (USD MILLION)111
6.4INSTRUMENTS111
TABLE 39ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)112
TABLE 40ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)112
6.4.1SLIDE STAINING SYSTEMS112
6.4.1.1Availability of automated systems will drive market growth during the forecast period112
TABLE 41SLIDE STAINING SYSTEMS MARKET, BY REGION, 2016–2020 (USD MILLION)113
TABLE 42SLIDE STAINING SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION)113
6.4.2TISSUE PROCESSING SYSTEMS114
6.4.2.1Rising adoption of automation is a key trend in the tissue processing systems market114
TABLE 43TISSUE PROCESSING SYSTEMS MARKET, BY REGION,
2016–2020 (USD MILLION)114
TABLE 44TISSUE PROCESSING SYSTEMS MARKET, BY REGION,
2021–2026 (USD MILLION)114
6.4.3CELL PROCESSORS115
6.4.3.1Cell processors are used to remove unwanted matter in samples—making them important instruments in the market115
TABLE 45CELL PROCESSORS MARKET, BY REGION, 2016–2020 (USD MILLION)115
TABLE 46CELL PROCESSORS MARKET, BY REGION, 2021–2026 (USD MILLION)115
6.4.4MICROTOMES116
6.4.4.1Rotary microtomes are the most commonly used microtomes116
TABLE 47MICROTOMES MARKET, BY REGION, 2016–2020 (USD MILLION)116
TABLE 48MICROTOMES MARKET, BY REGION, 2021–2026 (USD MILLION)116
6.4.5EMBEDDING SYSTEMS117
6.4.5.1Liquid paraffin is the most commonly used embedding medium117
TABLE 49EMBEDDING SYSTEMS MARKET, BY REGION, 2016–2020 (USD MILLION)117
TABLE 50EMBEDDING SYSTEMS MARKET, BY REGION, 2021–2026 (USD MILLION)117
6.4.6COVERSLIPPERS118
6.4.6.1Coverslippers are widely used instruments in research118
TABLE 51COVERSLIPPERS MARKET, BY REGION, 2016–2020 (USD MILLION)118
TABLE 52COVERSLIPPERS MARKET, BY REGION, 2021–2026 (USD MILLION)118
6.4.7OTHER INSTRUMENTS119
TABLE 53OTHER INSTRUMENTS MARKET, BY REGION, 2016–2020 (USD MILLION)119
TABLE 54OTHER INSTRUMENTS MARKET, BY REGION, 2021–2026 (USD MILLION)119
7ANATOMIC PATHOLOGY MARKET, BY APPLICATION120
7.1INTRODUCTION121
7.1.1PRIMARY NOTES121
7.1.1.1Key industry insights121
TABLE 55ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)121
TABLE 56ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)121
7.2DISEASE DIAGNOSTICS122
TABLE 57ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2016–2020 (USD MILLION)122
TABLE 58ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, BY DISEASE TYPE, 2021–2026 (USD MILLION)122
7.2.1CANCER122
TABLE 59ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)123
TABLE 60ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)123
7.2.1.1Breast cancer123
7.2.1.1.1Breast cancer accounts for the highest mortality rate among cancers in North America123
TABLE 61BREAST CANCER INCIDENCE, BY REGION, 2020 VS. 2040124
TABLE 62ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION,
2016–2020 (USD MILLION)124
TABLE 63ANATOMIC PATHOLOGY MARKET FOR BREAST CANCER, BY REGION,
2021–2026 (USD MILLION)124
7.2.1.2Gastrointestinal cancer125
7.2.1.2.1The rising incidence of gastric cancer will boost the market growth125
TABLE 64COLORECTAL CANCER INCIDENCE, BY REGION, 2020 VS. 2040125
TABLE 65ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER,
BY REGION, 2016–2020 (USD MILLION)125
TABLE 66ANATOMIC PATHOLOGY MARKET FOR GASTROINTESTINAL CANCER,
BY REGION, 2021–2026 (USD MILLION)126
7.2.1.3Lung cancer126
7.2.1.3.1Lung cancer is the most common cancer in the world126
TABLE 67LUNG CANCER INCIDENCE, BY REGION, 2020 VS. 2040126
TABLE 68ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION,
2016–2020 (USD MILLION)127
TABLE 69ANATOMIC PATHOLOGY MARKET FOR LUNG CANCER, BY REGION,
2021–2026 (USD MILLION)127
7.2.1.4Prostate cancer127
7.2.1.4.1Prostate cancers are prevalent in the geriatric male population127
TABLE 70PROSTATE CANCER INCIDENCE, BY REGION, 2020 VS. 2040128
TABLE 71ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2016–2020 (USD MILLION)128
TABLE 72ANATOMIC PATHOLOGY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2026 (USD MILLION)128
7.2.1.5Other cancers129
TABLE 73MELANOMA INCIDENCE, BY REGION, 2020 VS. 2040129
TABLE 74ANATOMIC PATHOLOGY MARKET FOR OTHER CANCERS, BY REGION,
2016–2020 (USD MILLION)129
TABLE 75ANATOMIC PATHOLOGY MARKET FOR OTHER CANCERS, BY REGION,
2021–2026 (USD MILLION)130
7.2.2OTHER DISEASES130
TABLE 76ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2016–2020 (USD MILLION)131
TABLE 77ANATOMIC PATHOLOGY MARKET FOR OTHER DISEASES, BY REGION,
2021–2026 (USD MILLION)131
7.3MEDICAL RESEARCH131
7.3.1GROWING RESEARCH ACTIVITIES WILL DRIVE THE ADOPTION OF ANATOMIC PATHOLOGY PRODUCTS IN THIS APPLICATION SEGMENT131
TABLE 78ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2016–2020 (USD MILLION)132
TABLE 79ANATOMIC PATHOLOGY MARKET FOR MEDICAL RESEARCH, BY REGION, 2021–2026 (USD MILLION)132
8ANATOMIC PATHOLOGY MARKET, BY END USER133
8.1INTRODUCTION134
8.1.1PRIMARY NOTES134
8.1.1.1Key industry insights134
TABLE 80ANATOMIC PATHOLOGY MARKET, BY END USER, 2016–2020 (USD MILLION)134
TABLE 81ANATOMIC PATHOLOGY MARKET, BY END USER, 2021–2026 (USD MILLION)134
8.2HOSPITAL LABORATORIES135
8.2.1HOSPITAL LABORATORIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET135
TABLE 82ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2016–2020 (USD MILLION)135
TABLE 83ANATOMIC PATHOLOGY MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2021–2026 (USD MILLION)136
8.3CLINICAL LABORATORIES136
8.3.1INCREASING OUTPATIENT SURGERIES TO DRIVE THE GROWTH OF THIS SEGMENT136
TABLE 84ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2016–2020 (USD MILLION)137
TABLE 85ANATOMIC PATHOLOGY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2021–2026 (USD MILLION)137
8.4OTHER END USERS137
TABLE 86ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION,
2016–2020 (USD MILLION)138
TABLE 87ANATOMIC PATHOLOGY MARKET FOR OTHER END USERS, BY REGION,
2021–2026 (USD MILLION)138
9ANATOMIC PATHOLOGY MARKET, BY REGION139
9.1INTRODUCTION140
TABLE 88ANATOMIC PATHOLOGY MARKET, BY REGION, 2016–2020 (USD MILLION)140
TABLE 89ANATOMIC PATHOLOGY MARKET, BY REGION, 2021–2026 (USD MILLION)140
9.2NORTH AMERICA141
FIGURE 30NORTH AMERICA: CANCER INCIDENCE & MORTALITY, 2012–2035141
FIGURE 31NORTH AMERICA: ANATOMIC PATHOLOGY MARKET SNAPSHOT142
TABLE 90NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2020 (USD MILLION)142
TABLE 91NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2021–2026 (USD MILLION)143
TABLE 92NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION)143
TABLE 93NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)143
TABLE 94NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2016–2020 (USD MILLION)144
TABLE 95NORTH AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE, 2021–2026 (USD MILLION)144
TABLE 96NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)144
TABLE 97NORTH AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)145
TABLE 98NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION)145
TABLE 99NORTH AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)145
TABLE 100NORTH AMERICA: ANTIBODIES MARKET, BY TYPE,
2016–2020 (USD MILLION)146
TABLE 101NORTH AMERICA: ANTIBODIES MARKET, BY TYPE,
2021–2026 (USD MILLION)146
TABLE 102NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)146
TABLE 103NORTH AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)146
TABLE 104NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)147
TABLE 105NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)147
TABLE 106NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION)147
TABLE 107NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION)147
TABLE 108NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2020 (USD MILLION)148
TABLE 109NORTH AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021–2026 (USD MILLION)148
TABLE 110NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)148
TABLE 111NORTH AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)149
9.2.1US149
9.2.1.1The US dominates the global anatomic pathology market149
TABLE 112US: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040150
TABLE 113US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)150
TABLE 114US: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)151
TABLE 115US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)151
TABLE 116US: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)151
TABLE 117US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)152
TABLE 118US: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)152
TABLE 119US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)153
TABLE 120US: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)153
TABLE 121US: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)153
TABLE 122US: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)154
TABLE 123US: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)154
TABLE 124US: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)154
TABLE 125US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)154
TABLE 126US: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)155
TABLE 127US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)155
TABLE 128US: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)155
TABLE 129US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)156
TABLE 130US: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)156
TABLE 131US: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)156
TABLE 132US: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)157
9.2.2CANADA157
9.2.2.1High burden of cancer to support market growth157
TABLE 133CANADA: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040157
TABLE 134CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)158
TABLE 135CANADA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)158
TABLE 136CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)158
TABLE 137CANADA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)159
TABLE 138CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)159
TABLE 139CANADA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)159
TABLE 140CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)160
TABLE 141CANADA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)160
TABLE 142CANADA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)160
TABLE 143CANADA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)161
TABLE 144CANADA: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)161
TABLE 145CANADA: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)161
TABLE 146CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)161
TABLE 147CANADA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)162
TABLE 148CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION)162
TABLE 149CANADA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION)162
TABLE 150CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)163
TABLE 151CANADA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)163
TABLE 152CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)163
TABLE 153CANADA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)164
9.3EUROPE164
FIGURE 32EUROPE: CANCER INCIDENCE & MORTALITY, 2012–2035165
TABLE 154EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2020 (USD MILLION)165
TABLE 155EUROPE: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2021–2026 (USD MILLION)166
TABLE 156EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)166
TABLE 157EUROPE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)166
TABLE 158EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)167
TABLE 159EUROPE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)167
TABLE 160EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)167
TABLE 161EUROPE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)168
TABLE 162EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)168
TABLE 163EUROPE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)168
TABLE 164EUROPE: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)169
TABLE 165EUROPE: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)169
TABLE 166EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)169
TABLE 167EUROPE: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)169
TABLE 168EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)170
TABLE 169EUROPE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)170
TABLE 170EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION)170
TABLE 171EUROPE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION)170
TABLE 172EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)171
TABLE 173EUROPE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)171
TABLE 174EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)171
TABLE 175EUROPE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)172
9.3.1GERMANY172
9.3.1.1Availability of reimbursement for colorectal cancer screening to support market growth172
TABLE 176GERMANY: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040173
TABLE 177GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION)173
TABLE 178GERMANY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)173
TABLE 179GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)173
TABLE 180GERMANY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)174
TABLE 181GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)174
TABLE 182GERMANY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)174
TABLE 183GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION)175
TABLE 184GERMANY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)175
TABLE 185GERMANY: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)175
TABLE 186GERMANY: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)176
TABLE 187GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)176
TABLE 188GERMANY: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)176
TABLE 189GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)176
TABLE 190GERMANY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)177
TABLE 191GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION)177
TABLE 192GERMANY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION)177
TABLE 193GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)178
TABLE 194GERMANY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)178
TABLE 195GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)178
TABLE 196GERMANY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)179
9.3.2FRANCE179
9.3.2.1Government funding for cancer diagnosis & prevention to support market growth179
TABLE 197FRANCE: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040180
TABLE 198FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)180
TABLE 199FRANCE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)180
TABLE 200FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)180
TABLE 201FRANCE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)181
TABLE 202FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)181
TABLE 203FRANCE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)181
TABLE 204FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)182
TABLE 205FRANCE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)182
TABLE 206FRANCE: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)182
TABLE 207FRANCE: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)183
TABLE 208FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)183
TABLE 209FRANCE: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)183
TABLE 210FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)183
TABLE 211FRANCE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)184
TABLE 212FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION)184
TABLE 213FRANCE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION)184
TABLE 214FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)185
TABLE 215FRANCE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)185
TABLE 216FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)185
TABLE 217FRANCE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)186
9.3.3UK186
9.3.3.1Government initiatives to drive market growth in the UK186
TABLE 218UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)187
TABLE 219UK: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)187
TABLE 220UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)187
TABLE 221UK: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)187
TABLE 222UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)188
TABLE 223UK: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)188
TABLE 224UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)189
TABLE 225UK: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)189
TABLE 226UK: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)189
TABLE 227UK: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)190
TABLE 228UK: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)190
TABLE 229UK: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)190
TABLE 230UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)190
TABLE 231UK: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)191
TABLE 232UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)191
TABLE 233UK: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)191
TABLE 234UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)192
TABLE 235UK: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)192
TABLE 236UK: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)192
TABLE 237UK: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)193
9.3.4ITALY193
9.3.4.1Growing geriatric population to support market growth in Italy193
TABLE 238ITALY: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025194
TABLE 239ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)194
TABLE 240ITALY: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)194
TABLE 241ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)195
TABLE 242ITALY: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)195
TABLE 243ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)195
TABLE 244ITALY: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)196
TABLE 245ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)196
TABLE 246ITALY: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)196
TABLE 247ITALY: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)197
TABLE 248ITALY: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)197
TABLE 249ITALY: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)197
TABLE 250ITALY: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)197
TABLE 251ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)198
TABLE 252ITALY: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)198
TABLE 253ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)198
TABLE 254ITALY: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)198
TABLE 255ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)199
TABLE 256ITALY: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)199
TABLE 257ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)199
TABLE 258ITALY: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)200
9.3.5SPAIN200
9.3.5.1High incidence of chronic diseases to drive the Spanish market200
TABLE 259SPAIN: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025200
TABLE 260SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)201
TABLE 261SPAIN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)201
TABLE 262SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)201
TABLE 263SPAIN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)202
TABLE 264SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)202
TABLE 265SPAIN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)202
TABLE 266SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)203
TABLE 267SPAIN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)203
TABLE 268SPAIN: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)203
TABLE 269SPAIN: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)204
TABLE 270SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)204
TABLE 271SPAIN: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)204
TABLE 272SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)204
TABLE 273SPAIN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)205
TABLE 274SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)205
TABLE 275SPAIN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)205
TABLE 276SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)206
TABLE 277SPAIN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)206
TABLE 278SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)206
TABLE 279SPAIN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)207
9.3.6REST OF EUROPE207
TABLE 280ROE: CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040207
TABLE 281ROE: LUNG CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040207
TABLE 282ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)208
TABLE 283ROE: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)208
TABLE 284ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)209
TABLE 285ROE: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)209
TABLE 286ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)209
TABLE 287ROE: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)210
TABLE 288ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)210
TABLE 289ROE: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)210
TABLE 290ROE: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)211
TABLE 291ROE: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)211
TABLE 292ROE: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)211
TABLE 293ROE: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)211
TABLE 294ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)212
TABLE 295ROE: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)212
TABLE 296ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)212
TABLE 297ROE: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)212
TABLE 298ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)213
TABLE 299ROE: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)213
TABLE 300ROE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)213
TABLE 301ROE: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)214
9.4ASIA PACIFIC214
FIGURE 33ASIA PACIFIC: CANCER INCIDENCE & MORTALITY, 2012–2035215
FIGURE 34ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET SNAPSHOT216
TABLE 302ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2016–2020 (USD MILLION)216
TABLE 303ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY COUNTRY,
2021–2026 (USD MILLION)217
TABLE 304ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION)217
TABLE 305ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)217
TABLE 306ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)218
TABLE 307ASIA PACIFIC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)218
TABLE 308ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)218
TABLE 309ASIA PACIFIC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)219
TABLE 310ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION)219
TABLE 311ASIA PACIFIC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)219
TABLE 312ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)220
TABLE 313ASIA PACIFIC: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)220
TABLE 314ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)220
TABLE 315ASIA PACIFIC: KITS & REAGENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)220
TABLE 316ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)221
TABLE 317ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)221
TABLE 318ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION)221
TABLE 319ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION)221
TABLE 320ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2020 (USD MILLION)222
TABLE 321ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021–2026 (USD MILLION)222
TABLE 322ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)222
TABLE 323ASIA PACIFIC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)223
9.4.1JAPAN223
9.4.1.1Presence of a well-developed healthcare system to support market growth in Japan223
TABLE 324JAPAN: CANCER INCIDENCE, BY TYPE OF CANCER, 2020 VS. 2040224
TABLE 325JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)224
TABLE 326JAPAN: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)224
TABLE 327JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)224
TABLE 328JAPAN: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)225
TABLE 329JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)225
TABLE 330JAPAN: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)225
TABLE 331JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)226
TABLE 332JAPAN: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)226
TABLE 333JAPAN: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)226
TABLE 334JAPAN: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)227
TABLE 335JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)227
TABLE 336JAPAN: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)227
TABLE 337JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)227
TABLE 338JAPAN: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)228
TABLE 339JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)228
TABLE 340JAPAN: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)228
TABLE 341JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)229
TABLE 342JAPAN: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)229
TABLE 343JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)229
TABLE 344JAPAN: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)230
9.4.2CHINA230
9.4.2.1High investments in R&D to drive the market growth230
TABLE 345CHINA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025230
TABLE 346CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)231
TABLE 347CHINA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)231
TABLE 348CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)231
TABLE 349CHINA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)231
TABLE 350CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)232
TABLE 351CHINA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)232
TABLE 352CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)233
TABLE 353CHINA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)233
TABLE 354CHINA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)233
TABLE 355CHINA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)234
TABLE 356CHINA: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)234
TABLE 357CHINA: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)234
TABLE 358CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)234
TABLE 359CHINA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)235
TABLE 360CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)235
TABLE 361CHINA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)235
TABLE 362CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)236
TABLE 363CHINA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)236
TABLE 364CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)236
TABLE 365CHINA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)237
9.4.3INDIA237
9.4.3.1Expanding healthcare sector in the country to drive market growth237
TABLE 366INDIA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025237
TABLE 367INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)238
TABLE 368INDIA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)238
TABLE 369INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)238
TABLE 370INDIA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)239
TABLE 371INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)239
TABLE 372INDIA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)239
TABLE 373INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)240
TABLE 374INDIA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)240
TABLE 375INDIA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)240
TABLE 376INDIA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)241
TABLE 377INDIA: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)241
TABLE 378INDIA: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)241
TABLE 379INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)241
TABLE 380INDIA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)242
TABLE 381INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)242
TABLE 382INDIA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)242
TABLE 383INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)243
TABLE 384INDIA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)243
TABLE 385INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)243
TABLE 386INDIA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)244
9.4.4REST OF ASIA PACIFIC244
TABLE 387ROAPAC: INCIDENCE OF CANCER, BY COUNTRY, 2020 VS. 2040245
TABLE 388ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)245
TABLE 389ROAPAC: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)245
TABLE 390ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)246
TABLE 391ROAPAC: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)246
TABLE 392ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)246
TABLE 393ROAPAC: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)247
TABLE 394ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)247
TABLE 395ROAPAC: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)247
TABLE 396ROAPAC: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)248
TABLE 397ROAPAC: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)248
TABLE 398ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)248
TABLE 399ROAPAC: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)248
TABLE 400ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)249
TABLE 401ROAPAC: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)249
TABLE 402ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION)249
TABLE 403ROAPAC: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION)249
TABLE 404ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)250
TABLE 405ROAPAC: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)250
TABLE 406ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)250
TABLE 407ROAPAC: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)251
9.5REST OF THE WORLD251
TABLE 408ROW: ANATOMIC PATHOLOGY MARKET, BY REGION,
2016–2020 (USD MILLION)251
TABLE 409ROW: ANATOMIC PATHOLOGY MARKET, BY REGION,
2021–2026 (USD MILLION)252
TABLE 410ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)252
TABLE 411ROW: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)252
TABLE 412ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)252
TABLE 413ROW: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)253
TABLE 414ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)253
TABLE 415ROW: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)253
TABLE 416ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)254
TABLE 417ROW: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)254
TABLE 418ROW: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)254
TABLE 419ROW: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)255
TABLE 420ROW: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)255
TABLE 421ROW: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)255
TABLE 422ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)255
TABLE 423ROW: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)256
TABLE 424ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)256
TABLE 425ROW: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)256
TABLE 426ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)257
TABLE 427ROW: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)257
TABLE 428ROW: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)257
TABLE 429ROW: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)258
9.5.1LATIN AMERICA258
9.5.1.1Cancer screening programs to support market growth258
TABLE 430LUNG CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025258
TABLE 431LIVER CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025259
TABLE 432BREAST CANCER INCIDENCE IN KEY LATIN AMERICAN COUNTRIES,
2018 VS. 2025259
TABLE 433LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2016–2020 (USD MILLION)260
TABLE 434LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE, 2021–2026 (USD MILLION)260
TABLE 435LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)260
TABLE 436LATIN AMERICA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)261
TABLE 437LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)261
TABLE 438LATIN AMERICA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)261
TABLE 439LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2016–2020 (USD MILLION)262
TABLE 440LATIN AMERICA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE, 2021–2026 (USD MILLION)262
TABLE 441LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)262
TABLE 442LATIN AMERICA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)263
TABLE 443LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)263
TABLE 444LATIN AMERICA: KITS & REAGENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)263
TABLE 445LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)263
TABLE 446LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)264
TABLE 447LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2016–2020 (USD MILLION)264
TABLE 448LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS, 2021–2026 (USD MILLION)264
TABLE 449LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2016–2020 (USD MILLION)265
TABLE 450LATIN AMERICA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE, 2021–2026 (USD MILLION)265
TABLE 451LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)265
TABLE 452LATIN AMERICA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)266
9.5.2MIDDLE EAST & AFRICA266
9.5.2.1Increasing incidence of cancer in Africa to support market growth266
TABLE 453AFRICA: CANCER INCIDENCE, BY TYPE OF CANCER, 2018 VS. 2025266
TABLE 454MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2016–2020 (USD MILLION)267
TABLE 455MEA: ANATOMIC PATHOLOGY MARKET, BY PRODUCT & SERVICE,
2021–2026 (USD MILLION)267
TABLE 456MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2016–2020 (USD MILLION)268
TABLE 457MEA: ANATOMIC PATHOLOGY SERVICES MARKET, BY TYPE,
2021–2026 (USD MILLION)268
TABLE 458MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2016–2020 (USD MILLION)268
TABLE 459MEA: ANATOMIC PATHOLOGY INSTRUMENTS MARKET, BY TYPE,
2021–2026 (USD MILLION)269
TABLE 460MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2016–2020 (USD MILLION)269
TABLE 461MEA: ANATOMIC PATHOLOGY CONSUMABLES MARKET, BY TYPE,
2021–2026 (USD MILLION)269
TABLE 462MEA: ANTIBODIES MARKET, BY TYPE, 2016–2020 (USD MILLION)270
TABLE 463MEA: ANTIBODIES MARKET, BY TYPE, 2021–2026 (USD MILLION)270
TABLE 464MEA: KITS & REAGENTS MARKET, BY TYPE, 2016–2020 (USD MILLION)270
TABLE 465MEA: KITS & REAGENTS MARKET, BY TYPE, 2021–2026 (USD MILLION)270
TABLE 466MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2016–2020 (USD MILLION)271
TABLE 467MEA: ANATOMIC PATHOLOGY MARKET, BY APPLICATION,
2021–2026 (USD MILLION)271
TABLE 468MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2016–2020 (USD MILLION)271
TABLE 469MEA: ANATOMIC PATHOLOGY MARKET FOR DISEASE DIAGNOSTICS,
2021–2026 (USD MILLION)271
TABLE 470MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2016–2020 (USD MILLION)272
TABLE 471MEA: ANATOMIC PATHOLOGY MARKET FOR CANCER, BY TYPE,
2021–2026 (USD MILLION)272
TABLE 472MEA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2016–2020 (USD MILLION)272
TABLE 473MEA: ANATOMIC PATHOLOGY MARKET, BY END USER,
2021–2026 (USD MILLION)273
10COMPETITIVE LANDSCAPE274
10.1OVERVIEW274
10.2KEY PLAYER STRATEGIES/RIGHT TO WIN274
TABLE 474OVERVIEW OF STRATEGIES ADOPTED BY KEY MARKET PLAYERS274
10.3REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (INSTRUMENTS AND CONSUMABLES)275
FIGURE 35REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ANATOMIC PATHOLOGY MARKET (INSTRUMENTS AND CONSUMABLES)276
10.4MARKET SHARE ANALYSIS (INSTRUMENTS AND CONSUMABLES)276
FIGURE 36ANATOMIC PATHOLOGY MARKET SHARE ANALYSIS, 2020 (INSTRUMENTS AND CONSUMABLES)276
TABLE 475ANATOMIC PATHOLOGY MARKET (INSTRUMENTS AND CONSUMABLES): DEGREE OF COMPETITION (2020)277
10.5COMPANY EVALUATION QUADRANT278
10.5.1STARS278
10.5.2EMERGING LEADERS278
10.5.3PERVASIVE PLAYERS278
10.5.4PARTICIPANTS278
FIGURE 37ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020279
10.6COMPANY EVALUATION QUADRANT: SMES/START-UPS279
10.6.1PROGRESSIVE COMPANIES279
10.6.2STARTING BLOCKS279
10.6.3RESPONSIVE COMPANIES280
10.6.4DYNAMIC COMPANIES280
FIGURE 38ANATOMIC PATHOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR SMES & START-UPS, 2020280
10.7COMPETITIVE SCENARIO281
10.7.1PRODUCT LAUNCHES281
TABLE 476KEY PRODUCT LAUNCHES281
10.7.2DEALS282
TABLE 477KEY DEALS282
10.7.3OTHER DEVELOPMENTS283
TABLE 478OTHER KEY DEVELOPMENTS283
10.8COMPETITIVE BENCHMARKING284
10.8.1PRODUCT AND REGIONAL FOOTPRINT ANALYSIS284
TABLE 479PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN THE ANATOMIC PATHOLOGY MARKET FOR INSTRUMENTS AND CONSUMABLES284
TABLE 480PRODUCT FOOTPRINT OF COMPANIES285
TABLE 481REGIONAL FOOTPRINT OF COMPANIES286
 
11COMPANY PROFILES287
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1KEY PLAYERS287
11.1.1F. HOFFMAN-LA ROCHE LTD.287
TABLE 482F. HOFFMAN-LA ROCHE LTD.: BUSINESS OVERVIEW287
FIGURE 39COMPANY SNAPSHOT: F. HOFFMAN-LA ROCHE LTD. (2020)288
11.1.2DANAHER CORPORATION291
TABLE 483DANAHER CORPORATION: BUSINESS OVERVIEW291
FIGURE 40COMPANY SNAPSHOT: DANAHER (2020)292
11.1.3PHC HOLDINGS CORPORATION295
TABLE 484PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW295
11.1.4ABCAM PLC.297
TABLE 485ABCAM PLC.: BUSINESS OVERVIEW297
FIGURE 41COMPANY SNAPSHOT: ABCAM PLC. (2020)298
11.1.5HOLOGIC, INC.301
TABLE 486HOLOGIC, INC.: BUSINESS OVERVIEW301
FIGURE 42COMPANY SNAPSHOT: HOLOGIC, INC. (2020)302
11.1.6AGILENT TECHNOLOGIES304
TABLE 487AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW304
FIGURE 43COMPANY SNAPSHOT: AGILENT TECHNOLOGIES (2020)305
11.1.7BECTON, DICKINSON AND COMPANY307
TABLE 488BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW307
FIGURE 44COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020)308
11.1.8SAKURA FINETEK USA INC.310
TABLE 489SAKURA FINETEK: BUSINESS OVERVIEW310
11.1.9MERCK KGAA314
TABLE 490MERCK KGAA: BUSINESS OVERVIEW314
FIGURE 45COMPANY SNAPSHOT: MERCK KGAA (2020)315
11.1.10BIO SB317
TABLE 491BIO SB: BUSINESS OVERVIEW317
11.2OTHER PLAYERS319
11.2.1BIOGENEX319
11.2.2MILESTONE MEDICAL320
11.2.3HISTO-LINE LABORATORIES321
11.2.4DIAPATH S.P.A.322
11.2.5SLEE MEDICAL GMBH323
11.2.6AMOS SCIENTIFIC PTY LTD.324
11.2.7MEDITE MEDICAL GMBH325
11.2.8CELL SIGNALING TECHNOLOGY326
11.2.9CELLPATH LTD.327
11.2.10JINHUA YIDI MEDICAL APPLIANCE CO. LTD.328
11.2.11MICROS AUSTRIA329
11.2.12R. K. SCIENTIFIC INSTRUMENT PRIVATE LIMITED330
11.2.13LUPETEC331
11.2.14MEDIMEAS332
11.2.15BRIGHT INSTRUMENTS333
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12APPENDIX334
12.1INSIGHTS FROM INDUSTRY EXPERTS334
12.2DISCUSSION GUIDE334
12.3KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL339
12.4AVAILABLE CUSTOMIZATIONS341
12.5RELATED REPORTS342
12.6AUTHOR DETAILS343

お問合せフォーム